Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
79.99
-10.45 (-11.55%)
At close: Dec 5, 2025, 4:00 PM EST
80.02
+0.03 (0.04%)
After-hours: Dec 5, 2025, 7:43 PM EST
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $85.62 million as of December 5, 2025. Its market cap has increased by 337.89% in one year.
Market Cap
85.62M
Enterprise Value
76.30M
1-Year Change
337.89%
Ranking
Category
Stock Price
$79.99
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $85.62M, a decrease of -77.38%. That is a compound annual growth rate of -25.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 96.80M | 458.04% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |